Literature DB >> 10147242

The cost per treatment success.

N O Stãlhammar.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 10147242     DOI： 10.2165/00019053-199405040-00009

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

Authors:  M J Sculpher; M J Buxton
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981
  1 in total
  2 in total

Review 1.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.

Authors:  T Volmer; A Kielhorn; H H Weber; K J Wiessmann
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.